Sputnik V Ties Up With India's Dr Reddy's Labs For Vaccine

Published: Feb. 3, 2021, 6:02 p.m.

Sputnik V, the world's first registered vaccine based on a well-studied human adenoviral vector-based platform, has been peer reviewed by the Lancet Medical journal. Will it be India's third vaccine? Deepak Sapra, CEO, API and Pharmaceutical Services from Dr Reddy's Laboratories, joins us on Left, Right and Centre.